Shares of Rexahn Pharmaceuticals Inc. (REXN) are surging over 53% in pre-market today, after the company announced a definitive merger agreement with Ocuphire Pharma Inc., a privately-held clinical-stage ophthalmic biopharmaceutical company, under which Ocuphire would merge with a wholly-owned subsidiary of Rexahn in an all-stock transaction.
from RTT - Before the Bell https://ift.tt/2Ya3PYJ
via IFTTT
No comments:
Post a Comment